David R. Mason

946 citations
11 papers · 515 indexed · h-index 10
Topics
Botulinum Toxin and Related Neurological Disorders (7 papers)Microbial Inactivation Methods (2 papers)Bacterial Genetics and Biotechnology (2 papers)

In The Last Decade

David R. Mason

11 papers receiving 496 citations

Peers

David R. Mason
Comparison fields: 5 of 69
  • Neurology 254
  • Biotechnology 143
  • Molecular Biology 129
  • Cellular and Molecular Neuroscience 102
  • Food Science 85
Replace John D. Oultram with:
John D. Oultram United Kingdom
K Tomochika Japan
James T. Duff United States
Masahiro Yutani Japan
Amanda L. Miller United States
M Yajima Japan
Paul Heo South Korea
Holly J. Clarke Ireland
S. Paradisi Italy
Paolo Vatta Italy
David R. Mason relative to John D. Oultram United Kingdom John D. Oultram's profile →
Citations per field
00.5×11×
John D. Oultram · 1×
Citations per year

Countries citing papers authored by David R. Mason

Since Specialization
Citations

This map shows the geographic impact of David R. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Mason more than expected).

Fields of papers citing papers by David R. Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Mason. The network helps show where David R. Mason may publish in the future.

Co-authorship network of co-authors of David R. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Mason. A scholar is included among the top collaborators of David R. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Mason. David R. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 4
2 104
3 20
4 20
5 30
6 78
7 40
8 40
9 89
10 67
11 23

About David R. Mason

David R. Mason is a scholar working on Neurology, Biotechnology and Endocrinology, having authored 11 papers that have together received 515 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (7 papers), Microbial Inactivation Methods (2 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Neurology (254 citations), Biotechnology (143 citations) and Endocrinology (59 citations). David R. Mason has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Michael W. Peck, Ann F. Graham, Andrew T. Carter, Catherine J. Paul, Frédéric Carlin, Susan M. Twine, François Alberto, Mark Alston, Véronique Broussolle and John W. Austin. Their work appears in journals such as Applied and Environmental Microbiology, Oncogene and International Journal of Food Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026